Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1728
Gene Symbol: NQO1
NQO1
0.020 Biomarker disease BEFREE β-Lap-treated NQO1(+) cells died by programmed necrosis, whereas co-cultured NQO1(-) TNBC cells exhibited DNA damage and caspase-dependent apoptosis. 24512128 2014
Entrez Id: 1728
Gene Symbol: NQO1
NQO1
0.020 Biomarker disease BEFREE Dicoumarol increased survival of beta-lap-treated NQO1-expressing LNCaP transfectants. 11412042 2001
Entrez Id: 847
Gene Symbol: CAT
CAT
0.010 Biomarker disease BEFREE While B-LAP reduced malondialdehyde concentrations in heart of DOX-treated mice, it further promoted the activities of cardiac superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase (CAT).In accordance with increased cell survival, B-LAP significantly improved the cardiac function of DOX mice. 31630478 2020
Entrez Id: 3689
Gene Symbol: ITGB2
ITGB2
0.010 Biomarker disease BEFREE The Gram-negative bacterium Aggregatibacter actinomycetemcomitans, commonly associated with localized aggressive periodontitis (LAP), secretes an RTX (repeats-in-toxin) protein leukotoxin (LtxA) that targets human white blood cells, an interaction that is driven by its recognition of the lymphocyte function-associated antigen-1 (LFA-1) integrin. 29742342 2018
Entrez Id: 10404
Gene Symbol: CPQ
CPQ
0.010 Biomarker disease BEFREE This is the first report concerning leucine aminopeptidase from <i>E. granulosus</i>, and the results showed that Eg-LAP belong to M17 peptidase families, and that it is involved in important biological function of <i>E. granulosus</i>. 29614002 2018
Entrez Id: 3683
Gene Symbol: ITGAL
ITGAL
0.010 Biomarker disease BEFREE The Gram-negative bacterium Aggregatibacter actinomycetemcomitans, commonly associated with localized aggressive periodontitis (LAP), secretes an RTX (repeats-in-toxin) protein leukotoxin (LtxA) that targets human white blood cells, an interaction that is driven by its recognition of the lymphocyte function-associated antigen-1 (LFA-1) integrin. 29742342 2018
Entrez Id: 8767
Gene Symbol: RIPK2
RIPK2
0.010 Biomarker disease BEFREE Specifically, subjects with moderate LAP presented hypermethylation of both the upregulating (MAP3K7, MYD88, IL6R, and RIPK2) and downregulating (FADD, IRAK, and PPARA) genes, while severe LAP presented hypomethylation of these genes. 28883894 2017
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.010 Biomarker disease BEFREE Specifically, subjects with moderate LAP presented hypermethylation of both the upregulating (MAP3K7, MYD88, IL6R, and RIPK2) and downregulating (FADD, IRAK, and PPARA) genes, while severe LAP presented hypomethylation of these genes. 28883894 2017
Entrez Id: 6419
Gene Symbol: SETMAR
SETMAR
0.010 Biomarker disease BEFREE The administration of MaR1 at 1 nM enhanced phagocytosis (31 to 65% increase), intracellular antimicrobial reactive oxygen species production (26 to 71% increase), bacterial killing of these periodontal pathogens (22 to 38% reduction of bacterial titers), and restored impairment of LAP phagocytes. 26667839 2015
Entrez Id: 388015
Gene Symbol: RTL1
RTL1
0.010 Biomarker disease BEFREE The administration of MaR1 at 1 nM enhanced phagocytosis (31 to 65% increase), intracellular antimicrobial reactive oxygen species production (26 to 71% increase), bacterial killing of these periodontal pathogens (22 to 38% reduction of bacterial titers), and restored impairment of LAP phagocytes. 26667839 2015
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.010 AlteredExpression disease BEFREE Our findings demonstrate that the detection of Aa in LAP affected sites, did not correlate with clinical severity of the disease at the time of sampling in this cross-sectional study, although it did associate with lower local levels of IL-8, a different subgingival bacterial profile and elevated LPS-induced levels of TNFα and IL1β. 24376864 2013
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.010 AlteredExpression disease BEFREE Our findings demonstrate that the detection of Aa in LAP affected sites, did not correlate with clinical severity of the disease at the time of sampling in this cross-sectional study, although it did associate with lower local levels of IL-8, a different subgingival bacterial profile and elevated LPS-induced levels of TNFα and IL1β. 24376864 2013
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.010 AlteredExpression disease BEFREE Our findings demonstrate that the detection of Aa in LAP affected sites, did not correlate with clinical severity of the disease at the time of sampling in this cross-sectional study, although it did associate with lower local levels of IL-8, a different subgingival bacterial profile and elevated LPS-induced levels of TNFα and IL1β. 24376864 2013
Entrez Id: 7939
Gene Symbol: LAP
LAP
0.010 Biomarker disease BEFREE Immunohistology with an antibody against the latency-associated peptide (LAP (TGF-beta1)) showed a marked increase of inactive LAP-bound TGF-beta1 in wound healing and sclerotic skin whereas normal skin showed only a weak expression. 20195245 2010
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.010 Biomarker disease BEFREE Immunohistology with an antibody against the latency-associated peptide (LAP (TGF-beta1)) showed a marked increase of inactive LAP-bound TGF-beta1 in wound healing and sclerotic skin whereas normal skin showed only a weak expression. 20195245 2010
Entrez Id: 5163
Gene Symbol: PDK1
PDK1
0.010 Biomarker disease BEFREE The aim of this study was to test the hypothesis that PDK1 regulates chemotaxis in neutrophils and is responsible for the abnormal neutrophil chemotaxis LAP. 19892919 2009
Entrez Id: 3119
Gene Symbol: HLA-DQB1
HLA-DQB1
0.010 Biomarker disease BEFREE These results suggested that T. forsythia is associated with periodontal disease in Japanese adolescents and also suggested that HLA-DQB1 is related to LAP and is associated with T. forsythia infection. 19184295 2009
Entrez Id: 1429
Gene Symbol: CRYZ
CRYZ
0.010 AlteredExpression disease BEFREE Here we show that NAD(P)H:quinone oxidoreductase (NQO1/xip3) expression in human prostate cancer cells is a key determinant for apoptosis and lethality after beta-lap exposures. beta-Lap-treated, NQO1-deficient LNCaP cells were significantly more resistant to apoptosis than NQO1-expressing DU-145 or PC-3 cells after drug exposures. 11412042 2001